Sierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare Conference
11 Mars 2022 - 1:00PM
Business Wire
Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage
biopharmaceutical company dedicated to delivering targeted
therapies for rare cancers, today announced the company will
participate in the 32nd Annual Oppenheimer Healthcare Conference
being held virtually from March 15-17, 2022. President and Chief
Executive Officer Stephen Dilly, MBBS, PhD, will provide an
overview of the company on Tuesday, March 15, 2022, beginning at
3:20 pm ET.
A replay of the presentation will be available following the
conference on the Investors section of Sierra’s corporate website
in the Events & Webcast tab. The replay will be available for
approximately 30 days following the presentation.
About Sierra Oncology
Sierra Oncology is a late-stage biopharmaceutical company on a
mission to deliver targeted therapies that treat rare forms of
cancer. We harness our deep scientific expertise to identify
compounds that target the root cause of disease to advance targeted
therapies with assets on the leading edge of cancer biology. Our
team takes an evidence-based approach to understand the limitations
of current treatments and explore new ways to change the cancer
treatment paradigm. Together we are transforming promise into
patient impact.
For more information, visit www.SierraOncology.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220311005097/en/
Investor Contact DeDe Sheel
415.732.9828 dsheel@sierraoncology.com Media
Contact Lauren Musto 615.351.7777
lmusto@sierraoncology.com
Sierra Oncology (NASDAQ:SRRA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Sierra Oncology (NASDAQ:SRRA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Sierra Oncology Inc (NASDAQ): 0 recent articles
Plus d'articles sur Sierra Oncology, Inc.